If you have searched for FRABOC, you may have found an unfamiliar term with very little explanation. FRABOC, more formally written as FRA-BOC, refers to Familial Risk Assessment – Breast and Ovarian Cancer.
It was an Australian online clinical tool designed for health professionals to assess a woman’s risk of developing breast and ovarian cancer based on her family history. Cancer Australia confirms that the original FRA-BOC tool is no longer available on its website.
This is important because FRABOC is sometimes described online as though it were a current cancer test or diagnosis. It was neither. Its purpose was to help organize family-history information and support a health professional’s assessment of familial cancer risk.
What Does FRABOC Stand For?
FRABOC is commonly used as a shortened form of FRA-BOC.
The acronym stands for:
- FRA — Familial Risk Assessment
- BOC — Breast and Ovarian Cancer
Together, FRA-BOC means Familial Risk Assessment – Breast and Ovarian Cancer.
The name describes the tool’s purpose quite directly. It focused on whether a person’s family history of breast and ovarian cancer suggested an increased level of risk.
Cancer Australia describes FRA-BOC as an online tool intended for health professionals such as general practitioners and nurses.
What Was FRABOC Used For?
FRABOC was used to help health professionals assess familial risk by looking at patterns of cancer within a patient’s family.
Family history can be clinically useful because certain patterns may indicate a higher likelihood of developing breast or ovarian cancer or raise questions about a possible inherited cancer-predisposition variant.
A structured assessment could consider information such as:
- Which relatives had cancer
- The type of cancer diagnosed
- The person’s relationship to the affected relative
- The age at which cancer was diagnosed
- Whether cancers occurred among relatives on the same side of the family
- Whether multiple relevant cancers occurred within a family
The purpose was not to predict the future with certainty. Instead, the information could help a health professional decide whether additional assessment, screening, referral, or genetic evaluation might be appropriate.
Was FRABOC a Cancer Test?
No.
FRABOC was a risk-assessment tool, not a diagnostic test.
It did not determine whether someone currently had breast or ovarian cancer. It also did not directly examine a person’s DNA.
This distinction is important because a family history of cancer does not automatically mean that someone has an inherited cancer-causing genetic variant or will develop cancer.
Risk assessment and diagnosis are separate processes.
A person can have a family history that warrants additional assessment without having cancer themselves.
Was FRABOC a Genetic Test?
No.
FRABOC used family-history information rather than functioning as a laboratory genetic test.
Genetic testing is a separate clinical process that examines genetic material for particular variants. Depending on the circumstances, a health professional may recommend genetic counselling or testing after considering a person’s personal and family history.
Therefore, finding the term FRABOC in an older medical document does not mean that the person had a genetic test.
Who Was FRABOC Designed For?
FRABOC was primarily intended for health professionals, rather than as a general self-assessment calculator for patients.
Cancer Australia specifically describes the former tool as being designed for professionals such as:
- General practitioners
- Nurses
- Other healthcare professionals involved in risk assessment
This matters because interpreting family cancer history can be complicated.
For example, two families might both report breast cancer in a relative, but the significance can differ depending on the relative’s age at diagnosis, the number of affected relatives, the types of cancer involved, and other clinical information.
A professional assessment provides context that a simple online questionnaire may not capture.
Is FRABOC Still Available?
No. The original FRA-BOC tool is no longer available through the Cancer Australia website.
This explains why people searching for a working FRABOC calculator may find older references, archived documents, or articles discussing the tool but no current Cancer Australia version.
The retirement of FRABOC does not mean that family history is no longer relevant to cancer-risk assessment.
Instead, Australian practice has moved toward newer risk-assessment approaches.
BreastScreen Queensland specifically states that FRA-BOC is no longer available and identifies iPrevent as a current validated breast-cancer risk assessment and risk-management decision-support tool.
What Replaced FRABOC?
There is an important distinction between saying that FRABOC was “replaced” and saying that one identical tool simply took its place.
Current Australian guidance uses newer approaches that can incorporate a broader range of information.
iPrevent is one important current tool. BreastScreen Queensland describes it as a validated breast cancer risk assessment and risk-management decision-support tool designed to support discussions between women and their doctors.
Cancer Australia also currently directs people toward iPrevent and evidence-based genetics referral guidance rather than the former FRA-BOC tool.
So, if you find FRABOC mentioned in an older medical document, it is better understood as a historical clinical tool rather than something you should try to locate and use today.
How Did FRABOC Relate to Family History?
The central idea behind FRABOC was that the pattern of cancer within a family can provide useful information about risk.
For example, a clinician may want to know:
Which relatives were affected?
A cancer diagnosis in a close blood relative can have different implications from a diagnosis in a more distant relative.
How old were they when diagnosed?
The age at which a relative developed cancer can be an important part of assessing family history.
Were several relatives affected?
Multiple cases of relevant cancers within a family can provide additional information.
Were the cancers on the same side of the family?
Understanding whether cases occur predominantly on the maternal or paternal side can help clinicians interpret the family pattern.
These factors do not independently prove that someone has an inherited cancer syndrome. They are pieces of information used as part of a broader clinical assessment.
Why Is Family History Important?
Family history is one component of understanding cancer risk.
Cancer Australia continues to provide information about breast cancer risk and encourages appropriate discussions with healthcare professionals. It also notes that current risk-assessment tools can help guide prevention and screening discussions.
However, family history is not the same thing as certainty.
Having a parent, sibling, aunt, or another relative with cancer does not automatically mean that another family member will develop the disease.
Cancer risk can involve many factors, including genetics, age, reproductive history, previous medical conditions, and other personal or environmental factors.
That is one reason modern risk assessment has moved beyond a single family-history-focused tool.
FRABOC vs Modern Risk Assessment
| Feature | FRABOC | Current approach |
| Full name | Familial Risk Assessment – Breast and Ovarian Cancer | Varies by tool |
| Main purpose | Familial breast and ovarian cancer risk assessment | Broader risk assessment and management |
| Intended users | Health professionals | Health professionals |
| Current availability | No longer available | Newer tools are available |
| Genetic test | No | Depends on clinical circumstances |
| Cancer diagnosis | No | Separate clinical process |
| Example of current tool | Historical | iPrevent |
The table should not be interpreted as saying that iPrevent is simply an identical replacement for every function of FRABOC. Rather, it shows the transition from the former tool to newer approaches.
What Should You Do If You Find FRABOC in an Old Medical Document?
If an old referral letter, clinical note, family-history document, or medical resource mentions FRABOC, there is no need to assume that you must find the original calculator.
Instead, discuss the information with a qualified healthcare professional.
Bring as much accurate family-history information as possible, including:
- Which relatives had cancer
- The type of cancer
- Approximate age at diagnosis
- Whether multiple relatives were affected
- Any known genetic testing in the family
A healthcare professional can determine whether a current risk assessment or referral is appropriate.
Is FRABOC Related to Breast Cancer Screening?
FRABOC was related to risk assessment, which can inform conversations about screening and further management.
It was not itself a mammogram or breast-screening examination.
Current BreastScreen Queensland guidance distinguishes risk assessment from screening and provides information about services available to women considered at higher risk.
This distinction is useful because risk assessment and screening answer different questions.
Risk assessment asks, broadly, “How does this person’s risk compare with the expected population risk?”
Screening involves looking for signs of disease in people who may not have symptoms.
Is FRABOC Still Relevant Today?
Although the original tool is no longer available, the underlying subject remains relevant.
Family history continues to be an important part of evaluating breast and ovarian cancer risk. What has changed is the clinical tools and methods used to assess that risk.
For someone researching FRABOC today, the term is therefore most useful in two situations:
- Understanding an older Australian medical document
- Learning about the history of familial breast and ovarian cancer risk assessment
For current personal risk questions, newer clinical guidance should take priority over an old FRABOC assessment.
Frequently Asked Questions
What is FRABOC?
FRABOC, or FRA-BOC, stands for Familial Risk Assessment – Breast and Ovarian Cancer. It was an Australian online clinical tool for assessing familial breast and ovarian cancer risk.
Is FRABOC still available?
No. Cancer Australia states that the FRA-BOC tool is no longer available on its website.
Was FRABOC a genetic test?
No. It was a family-history-based risk-assessment tool, not a laboratory genetic test.
Was FRABOC used to diagnose cancer?
No. It assessed risk and did not diagnose breast or ovarian cancer.
Who used FRABOC?
It was designed for healthcare professionals, including general practitioners and nurses.
What replaced FRABOC?
Current Australian guidance points to newer risk-assessment approaches. BreastScreen Queensland specifically identifies iPrevent as a validated current breast cancer risk-assessment and management tool.
Can I still use an old FRABOC result?
An old result may provide historical context, but it should not be treated as a substitute for a current clinical risk assessment. Discuss your current risk with a qualified healthcare professional.
Conclusion
FRABOC is the shortened name for FRA-BOC, or Familial Risk Assessment – Breast and Ovarian Cancer. It was an Australian clinical tool designed to help health professionals assess breast and ovarian cancer risk using family-history information.
It was not a cancer diagnosis, screening examination, or genetic test. Cancer Australia now identifies FRA-BOC as a former tool that is no longer available on its website.
If you encounter FRABOC in an older document, the best way to understand it is as part of the history of Australian familial cancer-risk assessment. For current risk assessment, Australian health guidance now points toward newer tools such as iPrevent and appropriate professional assessment.